Purpose of Review For the more than 636,000 adults with end-stage renal disease (ESRD) in the USA, kidney transplantation is the preferred treatment compared to dialysis. Living donor kidney transplantation (LDKT) comprised 31% of kidney transplantations in 2015, an 8% decrease since 2004. We aimed to summarize the current literature on decision aids that could be used to improve LDKT rates. Recent Findings Decision aids are evidence-based tools designed to help patients and their families make difficult treatment decisions. LDKT decision aids can help ESRD patients, patients' family and friends, and healthcare providers engage in treatment decisions and thereby overcome multifactorial LDKT barriers. Summary We identified 12 LDKT decision aids designed to provide information about LDKT, and/or to help ESRD patients identify potential living donors, and/or to help healthcare providers make decisions about treatment for ESRD or living donation. Of these, four were shown to be effective in increasing LDKT, donor inquiries, LDKT knowledge, and willingness to discuss LDKT. Although each LDKT decision aid has limitations, adherence to decision aid development guidelines may improve decision aid utilization and access to LDKT.
Introduction
Kidney transplantation is the preferred treatment for most patients with end-stage renal disease (ESRD) compared to dialysis [1, 2] . With more than 636,000 adults diagnosed with ESRD [3] , the gap between the demand for kidneys and available organs continues to widen. Living donor kidney transplantation (LDKT) can help reduce the organ shortage. Recipients of LDKT have improved survival [1, 2, 4] and enhanced quality of life [1] compared to recipients of deceased donor kidney transplantation. However, LDKT comprised only 31% of kidney transplantations in 2013, an 8% decrease since 2004 [5, 6] , suggesting substantial barriers to pursuing LDKT.
While decisions about pursuing LDKT can be difficult to make [7, 8] , tools that assist potential recipients, potential donors, and/or their healthcare providers in making decisions may reduce uncertainty and possibly increase LDKT rates. Decision aids can help engage and inform patients of their treatment options by presenting evidence-based information. In this review, we highlight barriers to LDKT, define decision aids, describe strategies on how decision aids can overcome barriers to LDKT, and discuss the gaps and future research on and implementation of LDKT decision aids.
Barriers to Living Donor Kidney Transplantation
Barriers to LDKT are multifactorial [7] and include recipient and donor beliefs and characteristics [9] [10] [11] [12] [13] [14] [15] , healthcare provider attitudes toward LDKT [16] [17] [18] , and public opinion [19] [20] [21] .
This article is part of the Topical Collection on Live Kidney Donation Recipient and donor barriers include limited knowledge of the benefits of transplantation (including benefits of LKDT over other forms of transplantation), psychological denial about the need for a transplant [7, 9, 10] , cultural and religious concerns [11, 12] , and financial concerns [13-15, 19, 22] . Potential recipients may turn down living donor kidney offers to protect the potential donor from incurring risks or avoid asking people to donate because it is too challenging and/or may make others feel obligated to donate [8] . For living donors, financial barriers may affect LDKT [13, 15, 23] . A prospective study from seven Canadian transplant centers [15] stated 47% of living donors reported a loss of income with the average total out-of-pocket expenses and lost wages of $3268.
Healthcare provider's attitudes and perceptions of the appropriateness of LDKT for their patients may lead to lower LDKT rates and incomplete transplant evaluations [17, 18, 24] . Nephrologists who treat predominantly minority ESRD populations spend less time providing patient education and counseling on LDKT compared to nephrologists with fewer minority patients [16] , which may reflect providers' attitudes about their patients' suitability for transplant [24] . Provider perception of a potential recipient's or donor's reduced healthcare access and poor medical follow-up may also influence their attitude about the patient's suitability for LDKT [7] .
Public opinion toward LDKT is favorable, with the majority of the public (90%) considering LDKT an acceptable procedure and 76% [25] willing to consider potential living donation to a close friend [20, 25, 26] . However, negative attitudes and fear of the unknown remain in public opinion and potential donors reported being weary about risks such as decreased life expectancy, lifestyle limitations, relationship tension, and psychological distress in the event of recipient death or graft loss [20, 21] .
Among these barriers to LDKT, different subgroups may encounter different barriers in their access to LDKT [7, 8, 10, 27, 28] .
Decision Aid Overview
Decision aids are evidence-based tools designed to help patients and their families participate in making specific choices, such as LDKT, among other healthcare options [29, 30••, 31, 32] . Decision aids are designed to supplement clinician counseling. In other healthcare settings, decision aids have been shown to improve knowledge [33] [34] [35] [36] , improve patient-practitioner communication [37, 38] , and decrease decisional conflict [38] [39] [40] about treatment decisions. Decision aids prompt patient involvement in the healthcare decisionmaking process, which can contribute to better health outcomes [41] [42] [43] .
Decision aids can assume many forms such as a brochure, fact sheet, handbook, videos, website, smartphone applications, in-person, and social media applications. Across all forms, decision aids are developed through a process involving several steps. The development process presented by the International Patient Decision Aid Standards (IPDAS) Collaboration entails the following: (1) defining the purpose and scope of the decision aid, (2) forming a steering committee comprised of clinical experts and patients, (3) assessing patient needs, determining dissemination of decision aid, and reviewing the synthesized evidence, (4) creating the first draft of the decision aid and completing alpha-testing, (5) revising the decision aid based on clinician and patient feedbacks, (6) beta-testing the decision aid, (7) reviewing clinician and patient feedbacks to revise the decision aid, and (8) disseminating the decision aid [30••] (Fig. 1) .
The American Society of Transplantation's Live Donor Community of Practice held a consensus conference in 2014 to determine the best practices in educating patients and potential donors about LDKT [44••] . The Live Donor Community of Practice's education recommended offering culturally-tailored information that provides evidence-based comparison of the risk and benefits of LDKT. The recommendations also included potential living donor educational materials such as a summary of financial risks and estimation of costs [44••] . Decision aids can be utilized by transplant centers to meet the Live Donor Community of Practice's recommendation for education. We reviewed the literature and identified 12 decision aids ( Table 1 ) that provide educational resources on and/or serve to increase LDKT. While some of these decision aids overlap across categories, we broadly classified the 12 decision aids across the following types: (1) comprehensive LDKT education, (2) culturally sensitive and targeted to a specific audience, (3) recipient education, (4) potential donor recruitment and education, and (5) healthcare provider education. Four of these aids have completed evaluation and demonstrated effectiveness [45] [46] [47] [48] . Six are undergoing effectiveness testing [49] [50] [51] [52] [53] [54] (Table 2) .
Comprehensive LDKT Education Decision Aids
Although Centers for Medicare and Medicaid Services (CMS) mandates that ESRD patients be informed of all treatment options within 45 days of starting dialysis [55] , there are significant discrepancies between provider-and patient-reported patient education, with transplant education being reported by both patients and providers in only 56.2% of the participants [56] . Despite the CMS mandate, only a minority of the providers have a detailed discussion about kidney transplantation with patients [57] . Living donors desire additional information on LDKT beyond the CMS-mandated specific information [58] . In addition to information on health risks, financial concerns such as out-of-pocket expenses, lost wages, and insurance obtainment after donation are important for potential recipients and potential donors [13, 15, 23] . Decision aids that address the benefits of transplant, the transplantation process, targeted questions to assist patients make decisions, and financial materials for potential recipients and potential living donors are helpful to understand the breadth of commitment. Two decision aids that provide a comprehensive LDKT education, including financial-related material, are identified and described in the succeeding paragraphs.
Providing Resources to Enhance African American Patients' Readiness to Make Decisions about Kidney Disease
The Providing Resources to Enhance African American Patients' Readiness to Make Decisions about Kidney Disease (PREPARED) provides patients with kidney disease informational and financial materials through a video and handbook [59] . PREPARED was designed in two phases to adhere to the IPDAS guidelines [30••] . The decision aid was designed to address the risks and benefits of treatment options for kidney disease including peritoneal dialysis, in-center hemodialysis, home dialysis, transplant, and conservative management [59] . The comprehensive materials can be accessed on the web (http://ckddecisions.org/prepared-materials/) and consist of a 50-min video, 159-page handbook, and 14-page mini-book "All of the Facts." The video provides patient testimonials and concerns from patients, family members, and healthcare professionals. The handbook and mini-book are written at a fourth and sixth grade reading level and present a value clarification exercise to help patients determine which treatment they prefer [59] . PREPARED's effectiveness to increase selfreported rates of LDKT consideration (clinicaltrials.gov protocol #NCT01439516) is currently being evaluated in a single-center, randomized control trial (n = 210) [50] .
The Big Ask, The Big Give
In 2003, the National Kidney Foundation developed a comprehensive online resource (https://www.kidney. org/transplantation/livingdonors) that provides information on LDKT [51] and was ranked the first among 86 LDKT online resources [60] . The resource is geared toward potential transplant recipients, potential living donors, family members, and healthcare professionals. After an overwhelming response from a 2014 living donor survey requesting a living donation campaign and more extensive online resources about donation and transplant, the National Kidney Foundation developed "The Big Ask, The Big Give" awareness campaign [51] . In accordance with IPDAS guidelines, the National Kidney Foundation conducted a needs assessment with living donors and ESRD patients, field-tested a website with their Kidney Advocacy Committee, and is being pilot-tested in two sites in Georgia. The National Kidney Foundation plans a national dissemination of The Big Ask, The Big Give at the conclusion of the pilot testing. In the interim, The Big Ask, The Big Give website (https://www.kidney.org/transplantation/ l i v i n g d o n o r s / b i g a s k a n d h t t p s : / / w w w. k i d n e y. org/transplantation/livingdonors/biggive) remains available to patients, families, potential donors, and healthcare professionals.
Culturally Sensitive or Audience-Specific Decision Aids

Living About Choices in Transplantation and Sharing
Prior research has shown that African Americans have less awareness of the benefits and risks to donors of living donation and have fewer potential living donors, compared to whites [7] . Living About Choices in Transplantation and Sharing (Living ACTS) [45] is a decision aid developed using the IPDAS guidelines and aimed at overcoming communication barriers related to LDKT that are culturally sensitive to African Americans. Living ACTS was adapted from a community project with local churches aimed to improve the public commitment to deceased donation [61] . Living ACTS is an educational and motivational DVD, supplemented by a booklet, that employs the two-dimensional model of cultural sensitivity in public health [62] and conceptualizes cultural Abbreviations: ESRD end stage renal disease, KDPI kidney donor profile index sensitivity using surface and deep structure. Living ACTS exemplifies surface structure by including people, places, and language important and familiar to the target audience while acknowledging the influential roles that family and family discussions have in African American healthcare decisionmaking. Living ACTS's single-center, randomized control, effectiveness trial (n = 268) found that Living ACTS participants had significantly improved knowledge and willingness to talk with family members immediately after viewing the DVD and booklet; the increased knowledge and willingness were maintained at the 6-month follow-up [45] .
Infόrmate: Inform Yourself About Living Kidney Donation for Hispanics/Latinos
Culturally targeted and Internet-based health interventions have been shown to be highly effective to train community health advisors [63] , improve depressive symptoms [64] , and increase smoking cessation [65] . Although the rate of Internet usage is comparable between Hispanics and non-Hispanics [66] , few websites about kidney transplantation address the Hispanic community's specific needs with regard to treatment options [67] . Infόrmate: Living Kidney Donation for Hispanics/Latinos (http://informate.org) is a culturally targeted, bilingual decision aid website designed to increase knowledge about living donation and transplantation for Hispanic kidney disease patients and their families and potential living donors [46] . The website [68] was developed, in partnership with the National Kidney Foundation of Illinois, following IPDAS guidelines using Resnicow's two-dimensional model of cultural sensitivity in public health [62] . Infόrmate was prepared at the fifth to eighth grade reading level and engages users through interactive graphics that the user can click through to expose current medical advice on frequently asked questions. The website offers a quiz to assess knowledge of transplant myths versus facts and provides PDFs to download summarizing the myths versus the facts and the risks and benefits to living donor kidney transplantation [46] . Infόrmate hosts 19 living donor and recipient testimonials, two telenovelas, and three drag-and-drop games [68] . A prospective, multisite randomized control trial (clinicaltrials.gov protocol #NCT01859871) of 282 patients and family members were exposed to three of six Infόrmate sections for a total of 30 min. Immediately following the intervention, participants showed significant increases in transplant and donation knowledge. These increases in knowledge were sustained at the 3-week follow-up [46] . Informate was also evaluated in a pretestposttest among 63 dialysis patients and was shown to significantly increase LDKT knowledge [69] .
Decision Aids for Potential Recipients
Your Path to Transplant
Patient-specific education may improve access to LDKT. Your Path to Transplant [52] is a computer-tailored intervention that generates individually tailored educational messages to ESRD patients based on the transtheoretical model of behavior change [70] , which holds that patients vary in their readiness to seek a transplant and that educational messages should be matched to the patient's stage of readiness. Your Path to Transplant includes personalized, telephonic coaching from experts trained in health communication, public health, psychology, or social work and supplemental educational materials, including videos, brochures and fact sheets, and feedback reports tailored to patients' readiness, knowledge, selfefficacy, and perceptions of the pros and cons of transplant pursuit [1] . Your Path to Transplant aims to improve LDKT readiness, self-efficacy, balance of pros versus cons, and knowledge, as well as pursuit of LDKT and ultimate receipt of LDKT. Your Path to Transplant's effectiveness is currently being evaluated (clinicaltrials.gov protocol #NCT02181114) through a randomized control trail of 900 transplant patients [52] .
Explore Transplant @ Home
Given that the majority (57%) of nephrologists spend <20 min educating their patients on transplant [71] , alternative patient education that can be completed at home or via telephone may be needed to help dialysis patients learn about transplant [72, 73] . Explore Transplant @ Home is a patient-education program that involves mailing home informational brochures, postcards, and fact sheets, as well as four 20-min videos to dialysis patients. In addition, motivational and interactive text messages that explain the benefits and risks of dialysis, deceased donor transplant, and LDKT are sent to patients [53] . In a current randomized control trial, the effectiveness of the Explore Transplant @ Home (clinicaltrials.gov protocol #NCT02268682) program on its own is being compared to use of the program supplemented by telephone support from a trained educator was provided to patients [6] . Explore Transplant @ Home modules were designed to be administered gradually and incrementally based on the transtheoretical model of behavior change [70] .
My Transplant Coach
The decision to remain on dialysis, accept different deceased donor kidneys, or pursue living donation is a complex one. The standard of care at many transplant centers is to communicate average, population-based, and non-tailored prognosis estimates to individual ESRD patients, if these estimates are communicated at all [5] . In a study among 388 incident dialysis patients, kidney transplantation provision of information was concordantly reported by 56.2% of both the nephrologist and patient [56] . Among those patients uninformed about transplantation, only 3% was listed for a kidney transplant [56] . In order to improve patient empowerment and education about all their treatment options, an iOS tablet application, My Transplant Coach, was designed by transplant surgeons, nephrologists, and medical educators. The tablet-based decision aid communicates pre-transplant mortality rate, median waiting time to kidney transplantation, and post-transplant patient survival through didactic, animated videos of diverse patients and donors learning, with professional voice-over performances, simulating the transplant evaluation process [54] . The application was designed to be culturally competent and usable by patients with low health literacy and numeracy. The effectiveness of My Transplant Coach is in progress. Preliminary data from a pilot study of 81 patients across two US transplant centers revealed 78% of participants reported that My Transplant Coach made them more comfortable talking to their healthcare providers about transplant. My Transplant Coach significantly increased participants' transplant knowledge pre-and post-intervention [54] .
iChoose Kidney
Similar to a decision aid, shared decision-making is a process of making a healthcare decision jointly by the patient, family, and healthcare provider [74] [75] [76] . The shared decision-making model integrates the healthcare provider's clinical expertise with patient values and beliefs to facilitate informed, joint healthcare decisions [75] [76] [77] . Shared decision aids are tools that may be utilized during shared decision-making and can help promote patient-centered care [78] . iChoose Kidney was developed as a shared decision aid for clinicians to discuss with patients the individualized risk predictions comparing short-term patient survival for kidney transplantation versus dialysis [79] . A multidisciplinary team developed iChoose Kidney to assist providers in discussing treatment options with patients at the start of dialysis and is available through the Internet (http://ichoosekidney.emory.edu/) or a mobile (iOS) app. iChoose Kidney presents the patient survival or mortality risk in a patient-friendly manner using both graphical and numeric representations [80] . iChoose Kidney followed the IPDAS guidelines [30••] for decision aid development, and best practices were used to ensure access for patients with low health literacy and numeracy [29, 81] . The effectiveness o f i C h o o s e K i d n e y (c l i n ic a l tr i a l s. g o v p r o t o c o l #NCT022355571) to increase knowledge regarding the transplant survival benefit compared to dialysis is currently being evaluated in a multicenter, randomized control trial among transplant candidates (n = 450) presenting at transplant evaluation [49] .
Decision Aids for Potential Donor Education and Recruitment
Transplant candidates are reluctant to discuss their illness and dialysis experience, which may hinder their pursuit of LDKT [82] [83] [84] and recruitment of potential living donors. Friends and family members are more eager to share the patient's story and spread awareness about their loved one's difficulties and needs [85] . Three decision aids have been developed to assist the recipient and their social network to recruit potential living donors.
Live Donor Champion
The Live Donor Champion is a decision aid that separates the living donor advocate from the transplant candidate [48] by recruiting a friend or family member of the transplant candidate as the "champion." The Live Donor Champion decision aid is intended to be delivered by transplant centers to help transplant candidates advocate for the recipients' health and overcome their reluctance to "ask for a favor." In a prospective pilot study at one transplant center, 15 waitlisted patients were asked to identify one Live Donor Champion. A matched control patient was identified for each intervention patient; patients were matched on age, sex, blood type, cause of ESRD, diabetes diagnosis, time on the waiting list, and education level [86, 87] . Live Donor Champions completed five trainings over a 6-month period that addressed common transplant barriers and best practice methods for initiating conversations about living donor kidney transplantation [48] . Live Donor Champions were found to be more comfortable initiating conversations with family and friends over time. Patients with a Live Donor Champion were significantly more likely to have more live donor inquiries to the transplant center and more LDKTs compared to matched controls [48] .
DONOR
A smartphone app, DONOR, was developed in line with IPDAS development guidelines and in collaboration with Facebook, to allow the transplant candidate to comfortably and indirectly share their narrative [47] through a series of prompted questions. Similar to other Facebook apps focused on organ donation [88] , DONOR includes links to educational resources on transplantation that have been vetted by transplant ethicists. The narrative and transplant educational links can be uploaded to the transplant candidate's Facebook page and easily shared by the candidate's social network. In a single-center, prospective cohort study of the DONOR app, 54 adult kidney-only or liver-only waitlisted patients created and posted their patient stories on Facebook. In total, the Facebook posts generated >400 of "likes" and shares within 1 month of the initial session, and 18 potential live donors contacted the transplant center on behalf of the participants, significantly more than their matched controls [47] .
ESRD Risk Tool for Kidney Donor Candidates
In addition to donor recruitment, potential donors should be informed of the health risks associated with LDKT. While CMS-mandated specific information is communicated to potential living donors [58] , living donors reported the CMS information only moderately helpful [23] . A national study of >96,000 live kidney donors documented a slightly higher risk of developing ESRD among live kidney donors compared to that among healthy controls [89] . While the lifetime risk of ESRD is no higher than the general demographics-matched US population, the live kidney donors should be educated about the risk. The ESRD Risk Tool for Kidney Donor Candidates is freely available online (http://www.transplantmodels. com/esrdrisk/) and calculates individualized risk estimates for ESRD for potential donors [90] . The risk equations were based on >4,933,000 patients from seven US cohorts. Risk equations were applied to 57,508 living kidney donors to calculate 15-year and lifetime ESRD incidence estimates [90] based on ten pre-donation health and demographic characteristics.
Decision Aids for Healthcare Providers
Live Donor KDPI
The Kidney Donor Profile Index (KDPI) was designed to classify deceased donor characteristics and estimate the risk of graft failure to the deceased donor kidney transplant recipient [91, 92] . Massie et al. designed a similar risk index to classify living donor kidneys to enable health professionals to quantify the health risk for their recipient [93] . The Live Donor KDPI was designed using the Scientific Registry of Transplant Recipients (SRTR) data system and the study population consisted of all adult first-time and kidney-only transplant recipients between January 1, 2005 and December 31, 2013. Thirteen characteristics were included in the final model and included characteristics such as donor's age, sex, body mass index, h i s t o r y o f c i g a r e t t e u s e , r e c i p i e n t 's sex, and donor:recipient ABO compatibility and HLA mismatch [93] . The Live Donor KDPI is freely available online (http://www.transplantmodels.com/lkdpi/) and is intended to guide healthcare providers to determine the potential transplant recipients' risk and enables comparison of recipient outcomes with different living donors to find the more compatible live donor for their recipient.
Remaining Gaps of Current Decision Aids
Our review included 12 decision aids for LDKT interventions that met the definition of a decision aid. There are other significant LDKT interventions, rather than decision aids, available to potential recipients and potential donors that were not described above. Rodrigue et al.'s House Calls trial [94] is one example of an innovative approach focusing on increasing living donation among African Americans that delivers personalized education in the potential recipient's or family member's home. In the House Calls effectiveness trial, the primary outcome is occurrence of LDKT and participants (n = 180) assigned to House Calls are encouraged to invite close family, friends, and co-workers to a culturally sensitive education session led by a trained health educator [94] . At the end of a 2-year follow-up, participants of the House Calls intervention were more likely to have living donor inquiries and evaluation [73] . House Calls' home-based group education approach was adapted to the Dutch population for ESRD patients who were unable to find a living donor [95] . The "Kidney Team at Home" provides an inperson consultation with a home educator for ESRD patients and their family and friends. The educators discussed verbal and written information on five concepts: (1) kidney disease overview, (2) dialysis, (3) kidney transplantation advantages, disadvantages, and the transplant process, (4) LKDT, and (5) open discussions on whether the individuals present have considered LDKT. "Kidney Team at Home" participants showed improved knowledge and attitudes toward LDKT and more LDKTs compared to participants randomized to standard care [95] . For donors and potential donors, the American Society of Transplantation's Live Donor Financial Toolkit [96] is an important online resource targeting potential living donors (https://www.myast.org/patient-information/livedonor-toolkit). The Live Donor Financial Toolkit includes eight chapters to educate the potential donor on estimated LKDT-associated costs, various funding programs that donors can apply to for financial assistance, frequently asked questions on fundraising and insurance, and legislative efforts and federal laws that exist related to LDKT [96] . Another intervention targeted to donors or potential donors is an E-health cognitive behavioral therapy [97, 98] . The E-health cognitive behavioral therapy is aimed to help donors or potential donors overcome feelings of ambivalence toward their donation decision and includes treatment modules on negative mood, social functioning, and communication to explore their feelings and thoughts about the donation decision [97] .
While our review is not a comprehensive list of LDKT interventions available to the kidney transplantation community, we have summarized the existing decision aids described in the literature that may help improve access to LDKT. Our review noted common limitations and gaps that exist in the decision aids presented above, according to the IPDAS guidelines [30••] (Table 2) . As presented in Fig. 1 , the crux of the IPDAS Guidelines is the following: (1) clearly defining the scope and target audience of the decision aid, (2) assembling stakeholders that include clinical experts and members of the intended audience to assist in development, and (3) repeated field testing and revising of the decision aid. The IPDAS guidelines emphasize careful planning to assure decision aid users of the reliability and validity of the tool.
The IPDAS guidelines stress that decision aids must be carefully developed and tested by the users [30••] . Involving a variety of stakeholders strengthens the internal validity and assures the decision aid is accomplishing the defined scope and reaching the target audience and is being tested using appropriate effectiveness measures [30••] . Stakeholders can also address potential barriers to implementing or using the decision aid. Few LDKT decision aids presented detailed information on the stakeholder's involvement [45, 53, 68, 79] and seldom reported if members of the target audience were involved in the LDKT decision aid development [29] . The peer review community should recognize the value of stakeholder involvement and importance of careful development and encourage investigators to report equally on those characteristics.
Four of the reviewed LDKT decision aids had evaluated their effectiveness. Six LDKT decision aids were in the process of evaluating their effectiveness. The IPDAS guidelines state the development process of decision aids should consist of multiple field tests and revisions, ultimately leading to distribution [30••] . While six (54.5%) decision aids communicated their decision aid development process [45-47, 51, 59, 79] , repeated field tests, revisions, and evaluations are needed to determine the l o n g -t e r m i m p a c t o f t h e L D K T d e c i s i o n a i d s . Investigators should build into their grant applications the need for additional testing, and funders should support such diligence in decision aid development. By assembling a group of stakeholders, including clinical experts and patients, a priori, investigators can plan for ongoing development within different sample populations that vary based on age, racial/ethnic background, and socioeconomic status. Effectiveness and usability testing in various populations will limit selection bias while enhancing the decision aid's generalizability. Long-term evaluation will also offer insights into decision aids' sustainable effects [88] . Researchers are encouraged to practice large-scale collaboration [99] and share ideas to improve research findings and reproducibility. Through collaboration, transplant centers may learn from others' best practices to improve their clinical processes and reduce the national variation in LDKT education [100] .
Conclusion
As the prevalence of ESRD continues to increase [3] , LDKT could shorten the wait time for many patients and improve their survival. While patients, potential donors, and healthcare professionals encounter barriers to LDKT, various decision aids have been developed and tested and are now available to assist patients and their families in making decisions about LDKT. Despite the extensive material provided to the ESRD community through several LDKT decision aids, some gaps remain in the development, effectiveness testing, and generalizability to a wider audience. In compliance with IPDAS guidelines, investigators are encouraged to assemble stakeholders that encompass experts and members of the target audience. Transplant centers are also encouraged to collaborate and develop overarching best practices aimed at improving access to LDKT.
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